Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02027259 · ClinicalTrials.gov registry record · NA
Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits
A NA study, sponsored by Providence VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02027259 is a NA study that has completed, run by Providence VA Medical Center. The registered enrollment target is 52 participants.
The verdict
NCT02027259, a NA study, has completed, sponsored by Providence VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether group visits with added behavioral activation (BA) for depression will have a greater clinical impact than our standard group visits without BA for depression in reducing the risk of future coronary events as measured by the United Kingdom Prospective Diabetes Study (UKPDS) risk engine and depression symptoms as measured by Patient Health Questionnaire-9 (PHQ-9) after 6 months.
Interventions
- BEHAVIORAL Behavioral activation (BA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2012-01-19 |
| Est. Completion | 2015-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02027259
The ClinicalTrials.gov registry entry for NCT02027259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence VA Medical Center, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavioral activation (BA) is the first listed.
NCT02027259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02027259 about?
NCT02027259 is a clinical study titled "Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits". The purpose of this study is to determine whether group visits with added behavioral activation (BA) for depression will have a greater clinical impact than our standard group visits without BA for depression in reducing the risk of future coronary events as measured by the United Kingdom Prospectiv...
What is the current status of trial NCT02027259?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2012-01-19. Estimated completion is 2015-10-02.
What interventions are being tested in trial NCT02027259?
The interventions under investigation include: Behavioral activation (BA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02027259?
This trial is sponsored by Providence VA Medical Center, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.